Drugs / Fecal Microbiota Transplantation (FMT)
Fecal Microbiota Transplantation (FMT)
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03928808 | Apr 2023 → Mar 2024 | anorexia nervosa | University of North Carolina, Chapel Hill | Withdrawn | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT03926286 | Apr 2019 → Jun 2020 | Sjogren syndrome | University of Miami | Completed | No outcome recorded |
| Phase 1 | NCT03772899 | Mar 2019 → Sep 2021 overdue | melanoma | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Active not recruiting | No outcome recorded |
| Phase 1 | NCT03006809 | Mar 2017 → May 2020 | ulcerative colitis | Najwa Elnachef | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07509346 | Jun 2026 → May 2029 expected | acute cholangitis | Puerta de Hierro University Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT02526849 | Nov 2015 → Dec 2016 | constipation disorder | Jinling Hospital, China | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05035342 | Jan 2024 → May 2026 overdue | bacterial infectious disease | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05538026 | Sep 2020 → Jan 2022 | ulcerative colitis | Bogomolets National Medical University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03802461 Comparator | Mar 2019 → Dec 2023 | infectious disease | Susy Hota | Suspended | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiota Transplantation (FMT) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03802461 ↗ |
| Known as | Fecal Microbial Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03772899 ↗ |
| Known as | Fecal transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05538026 ↗ |
| Known as | FMP30 | “FMP-30 containing frozen human fecal microbiota administered as (3) units of FMP30 enema on Day 0 and Week1” NCT03926286 ↗ |
| Known as | FMT | “Patients with recurrent acute cholangitis will receive FMT” NCT07509346 ↗ |
| Modality | Other / unclassified | “Fecal microbiota transplantation (FMT) is the transfer of stool from a healthy donor to a recipient to alter the composition of gut microbes.” NCT03802461 ↗ |
| Route | Other | “infused via nasointestinal tube” NCT02526849 ↗ |